ARS Pharmaceuticals Inc (NASDAQ: SPRY) is 50.81% higher on its value in year-to-date trading and has touched a low of $7.55 and a high of $18.51 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SPRY stock was last observed hovering at around $14.82 in the last trading session, with the day’s gains setting it 1.09%.
Currently trading at $15.91, the stock is 8.57% and 12.07% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.73 million and changing 7.35% at the moment leaves the stock 19.24% off its SMA200. SPRY registered 83.72% gain for a year compared to 6-month gain of 33.70%.
The stock witnessed a 11.57% loss in the last 1 month and extending the period to 3 months gives it a 36.57%, and is 10.95% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.07% over the week and 3.87% over the month.
ARS Pharmaceuticals Inc (SPRY) has around 160 employees, a market worth around $1.56B and $97.12M in sales. Profit margin for the company is -16.11%. Distance from 52-week low is 110.73% and -14.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.83%).
The EPS is expected to shrink by -1939.16% this year
The shares outstanding are 98.13M, and float is at 54.77M with Short Float at 31.29%.
The top institutional shareholder in the company is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with over 11.08 million shares valued at $94.27 million. The investor’s holdings represent 11.4409 of the SPRY Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 10.86 million shares valued at $92.43 million to account for 11.2168 of the shares outstanding. The other top investors are ORBIMED ADVISORS LLC which holds 9.24 million shares representing 9.5436 and valued at over $78.64 million, while BLACKROCK INC. holds 4.2182 of the shares totaling 4.08 million with a market value of $34.76 million.
ARS Pharmaceuticals Inc (SPRY) Insider Activity
ARS Pharmaceuticals Inc disclosed in a document filed with the SEC on May 20 ’25 that Fitzpatrick Alexander A (Chief Legal Officer) sold a total of 102,969 shares of the company’s common stock. The trade occurred on May 20 ’25 and was made at $14.10 per share for $1.45 million. Following the transaction, the insider now directly holds 89613.0 shares of the SPRY stock.
Still, SEC filings show that on May 20 ’25, SAUNDERS BRENT L (Director) disposed off 120,000 shares at an average price of $14.25 for $1.71 million. The insider now directly holds 0 shares of ARS Pharmaceuticals Inc (SPRY).
